Activity of Nafithromycin (WCK 4873) against Chlamydia pneumoniae.
Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Journal title
Antimicrobial agents and chemotherapyDate Published
2021-08-17Publication Volume
65Publication Issue
9Publication Begin page
e0058521
Metadata
Show full item recordCitation
Kohlhoff S, Hammerschlag MR. In Vitro Activity of Nafithromycin (WCK 4873) against Chlamydia pneumoniae. Antimicrob Agents Chemother. 2021 Aug 17;65(9):e0058521. doi: 10.1128/AAC.00585-21. Epub 2021 Aug 17. PMID: 34152817; PMCID: PMC8370221.DOI
10.1128/AAC.00585-21ae974a485f413a2113503eed53cd6c53
10.1128/AAC.00585-21
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 International
Related articles
- In Vitro Activity of the Novel Lactone Ketolide Nafithromycin (WCK 4873) against Contemporary Clinical Bacteria from a Global Surveillance Program.
- Authors: Flamm RK, Rhomberg PR, Sader HS
- Issue date: 2017 Dec
- In vitro activity of ABT 773, a new ketolide antibiotic, against Chlamydia pneumoniae.
- Authors: Strigl S, Roblin PM, Reznik T, Hammerschlag MR
- Issue date: 2000 Apr
- Comparison of Plasma and Intrapulmonary Concentrations of Nafithromycin (WCK 4873) in Healthy Adult Subjects.
- Authors: Rodvold KA, Gotfried MH, Chugh R, Gupta M, Friedland HD, Bhatia A
- Issue date: 2017 Sep
- In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae.
- Authors: Miyashita N, Fukano H, Yoshida K, Niki Y, Matsushima T
- Issue date: 2003 Sep
- In Vitro Activity of Levonadifloxacin (WCK 771) against Chlamydia pneumoniae.
- Authors: Kohlhoff S, Huerta N, Hammerschlag MR
- Issue date: 2019 Aug